Ligand-directed self-assembling chimeras for targeted protein O-GlcNAcylation

December 1, 2025·
Zhihao Guo
,
Tongyang Xu
,
Khadija Shahed Khan
Stephan Scheeff
Stephan Scheeff
,
Yao Qin
,
Sin-Yi Yu
,
Richard Lo
,
Yuanpei Li
,
Yalun Xie
,
Bowen Ma
,
Yunpeng Huang
,
Hillary Yui-Yan Yip
,
Clive Yik-Sham Chung
,
Tomonori Tamura
,
Itaru Hamachi
,
Billy Wai-Lung Ng
· 0 min read
DOI
Abstract
Precise control of protein-specific O-GlcNAcylation in cells remains a major challenge. Chemically induced proximity (CIP) offers a promising path forward, but its application to targeted protein O-GlcNAcylation has been limited by the lack of ligands that can bind the O-GlcNAc transferase (OGT) without inhibiting its catalytic function. Here, we repurpose a potent OGT inhibitor into a noninhibitory covalent probe using ligand-directed release chemistry (LDR). The resulting ligands covalently label OGT while preserving its enzymatic activity. Building on this scaffold, we developed a self-assembling O-GlcNAcylation Targeting Chimera (OGTAC) that recruits OGT to its native substrate casein kinase IIα (CK2α) in living cells, selectively elevating CK2α O-GlcNAcylation without affecting global modification levels. This new class of self-assembling chimeras covalently engages OGT to induce protein-specific O-GlcNAcylation, offering a versatile platform for dissecting and controlling this essential modification in living cells. Our findings open the door to next-generation OGTACs and related therapeutic strategies for the targeted modulation of the O-GlcNAc signaling.
Type
Publication
ACS Chem. Biol. 2025, 20, 12, 2907–2916
publications
Stephan Scheeff
Authors
Research Associate (Medicinal Chemistry)
Medicinal chemist designing novel antiviral and anticancer compounds. Researched nucleoside analogues at CUHK under Prof. Billy Ng since 2021, awarded Hong Kong Postdoctoral Fellowship 2022/2023. Enjoys exploring Hong Kong’s countryside and culture through photography.